{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:54:43Z","timestamp":1790391283915,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-D-112095"],"award-info":[{"award-number":["TSGH-D-112095"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C01-112024"],"award-info":[{"award-number":["TSGH-C01-112024"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2314-B-016 -019 -MY2"],"award-info":[{"award-number":["MOST 109-2314-B-016 -019 -MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-016-057"],"award-info":[{"award-number":["MOST 111-2314-B-016-057"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-016 -068 -MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-016 -068 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","award":["MAB_D_112004"],"award-info":[{"award-number":["MAB_D_112004"]}],"id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","award":["MND-MAB-C05-112019"],"award-info":[{"award-number":["MND-MAB-C05-112019"]}],"id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG000333"],"award-info":[{"award-number":["AG000333"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Technological Innovation R&D Program","award":["S2174574"],"award-info":[{"award-number":["S2174574"]}]},{"name":"Bio and Medical Technology Development Program","award":["NRF-2014M3A9B5073868"],"award-info":[{"award-number":["NRF-2014M3A9B5073868"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitochondria are essential organelles involved in cellular energy production. Changes in mitochondrial function can lead to dysfunction and cell death in aging and age-related disorders. Recent research suggests that mitochondrial dysfunction is closely linked to neurodegenerative diseases. Glucagon-like peptide-1 receptor (GLP-1R) agonist has gained interest as a potential treatment for Parkinson's disease (PD). However, the exact mechanisms responsible for the therapeutic effects of GLP-1R-related agonists are not yet fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we explores the effects of early treatment with PT320, a sustained release formulation of the GLP-1R agonist Exenatide, on mitochondrial functions and morphology in a progressive PD mouse model, the MitoPark (MP) mouse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our findings demonstrate that administration of a clinically translatable dose of PT320 ameliorates the reduction in tyrosine hydroxylase expression, lowers reactive oxygen species (ROS) levels, and inhibits mitochondrial cytochrome c release during nigrostriatal dopaminergic denervation in MP mice. PT320 treatment significantly preserved mitochondrial function and morphology but did not influence the reduction in mitochondria numbers during PD progression in MP mice. Genetic analysis indicated that the cytoprotective effect of PT320 is attributed to a reduction in the expression of mitochondrial fission protein 1 (Fis1) and an increase in the expression of optic atrophy type 1 (Opa1), which is known to play a role in maintaining mitochondrial homeostasis and decreasing cytochrome c release through remodeling of the cristae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that the early administration of PT320 shows potential as a neuroprotective treatment for PD, as it can preserve mitochondrial function. Through enhancing mitochondrial health by regulating Opa1 and Fis1, PT320 presents a new neuroprotective therapy in PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12929-024-01025-6","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T21:01:55Z","timestamp":1713301315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice"],"prefix":"10.1186","volume":"31","author":[{"given":"Vicki","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Tai","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eagle Yi-Kung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Lun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-II","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-4328","authenticated-orcid":false,"given":"Yuan-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"1025_CR1","first-page":"1","volume":"31","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag A-E, Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017;31:1\u201321.","journal-title":"Nat Rev Dis Primers"},{"key":"1025_CR2","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/science.1098966","volume":"3045674","author":"JT Greenamyre","year":"2004","unstructured":"Greenamyre JT, Hastings TG. Parkinson\u2019s\u2013divergent causes, convergent mechanisms. Science. 2004;3045674:1120\u20132.","journal-title":"Science"},{"key":"1025_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-018-0829-3","volume":"18","author":"J-S Park","year":"2018","unstructured":"Park J-S, Davis RL, Sue CM. Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep. 2018;18:1\u201311.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1025_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-018-0044-6","volume":"41","author":"AK Reeve","year":"2018","unstructured":"Reeve AK, Grady JP, Cosgrave EM, Bennison E, Chen C, Hepplewhite PD, Morris CM. Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 2018;41:9.","journal-title":"npj Parkinson's Dis"},{"key":"1025_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.expneurol.2009.03.019","volume":"2182","author":"VS Van Laar","year":"2009","unstructured":"Van Laar VS, Berman SB. Mitochondrial dynamics in Parkinson\u2019s disease. Exp Neurol. 2009;2182:247\u201356.","journal-title":"Exp Neurol"},{"key":"1025_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"543","author":"A Schapira","year":"1990","unstructured":"Schapira A, Cooper J, Dexter D, Clark J, Jenner P, Marsden C. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem. 1990;543:823\u20137.","journal-title":"J Neurochem"},{"key":"1025_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41583-023-00676-y","volume":"244","author":"J Drouin-Ouellet","year":"2023","unstructured":"Drouin-Ouellet J. Mitochondrial complex I deficiency and Parkinson disease. Nat Rev Neurosci. 2023;244:193.","journal-title":"Nat Rev Neurosci"},{"key":"1025_CR8","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1002\/ana.410320720","volume":"32S1","author":"AH Schapira","year":"1992","unstructured":"Schapira AH, Mann VM, Cooper JM, Krige D, Jenner PJ, Marsden CD. Mitochondrial function in Parkinson\u2019s disease. Ann Neur. 1992;32S1:S116\u201324.","journal-title":"Ann Neur"},{"key":"1025_CR9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1073\/pnas.0605208103","volume":"1044","author":"MI Ekstrand","year":"2007","unstructured":"Ekstrand MI, Terzioglu M, Galter D, Zhu S, Hofstetter C, Lindqvist E, Thams S, Bergstrand A, Hansson FS, Trifunovic A. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci. 2007;1044:1325\u201330.","journal-title":"Proc Natl Acad Sci"},{"key":"1025_CR10","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1089\/ars.2011.4200","volume":"169","author":"A Trancikova","year":"2012","unstructured":"Trancikova A, Tsika E, Moore DJ. Mitochondrial dysfunction in genetic animal models of Parkinson\u2019s disease. Antioxid Redox Signal. 2012;169:896\u2013919.","journal-title":"Antioxid Redox Signal"},{"key":"1025_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/5089","volume":"211","author":"J Wang","year":"1999","unstructured":"Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, Rustin P, Br\u00fcning JC, Kahn CR, Clayton DA, Barsh GS. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet. 1999;211:133\u20137.","journal-title":"Nat Genet"},{"key":"1025_CR12","doi-asserted-by":"publisher","first-page":"15066","DOI":"10.1073\/pnas.232591499","volume":"9923","author":"A Wredenberg","year":"2002","unstructured":"Wredenberg A, Wibom R, Wilhelmsson H, Graff C, Wiener HH, Burden SJ, Oldfors A, Westerblad H, Larsson N-G. Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci. 2002;9923:15066\u201371.","journal-title":"Proc Natl Acad Sci"},{"key":"1025_CR13","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1016\/S1353-8020(09)70811-9","volume":"15","author":"MI Ekstrand","year":"2009","unstructured":"Ekstrand MI, Galter D. The MitoPark Mouse\u2013An animal model of Parkinson\u2019s disease with impaired respiratory chain function in dopamine neurons. Parkinsonism Relat Disord. 2009;15:S185\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"1025_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/jnc.14702","volume":"1501","author":"YH Chen","year":"2019","unstructured":"Chen YH, Hsieh TH, Kuo TT, Kao JH, Ma KH, Huang EYK, Chou YC, Olson L, Hoffer BJ. Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors. J Neurochem. 2019;1501:56\u201373.","journal-title":"J Neurochem"},{"key":"1025_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1601-183X.2009.00542.x","volume":"92","author":"D Galter","year":"2010","unstructured":"Galter D, Pernold K, Yoshitake T, Lindqvist E, Hoffer B, Kehr J, Larsson NG, Olson L. MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson\u2019s disease. Genes Brain Behavior. 2010;92:173\u201381.","journal-title":"Genes Brain Behavior"},{"key":"1025_CR16","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1096\/fj.10-173625","volume":"254","author":"CH Good","year":"2011","unstructured":"Good CH, Hoffman AF, Hoffer BJ, Chefer VI, Shippenberg TS, B\u00e4ckman CM, Larsson N-G, Olson L, Gellhaar S, Galter D. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson\u2019s disease. FASEB J. 2011;254:1333.","journal-title":"FASEB J"},{"key":"1025_CR17","doi-asserted-by":"publisher","first-page":"12937","DOI":"10.1073\/pnas.1103295108","volume":"10831","author":"FH Sterky","year":"2011","unstructured":"Sterky FH, Lee S, Wibom R, Olson L, Larsson N-G. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci. 2011;10831:12937\u201342.","journal-title":"Proc Natl Acad Sci"},{"key":"1025_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuropharm.2018.01.040","volume":"136","author":"C H\u00f6lscher","year":"2018","unstructured":"H\u00f6lscher C. Novel dual GLP-1\/GIP receptor agonists show neuroprotective effects in Alzheimer\u2019s and Parkinson\u2019s disease models. Neuropharmacology. 2018;136:251\u20139.","journal-title":"Neuropharmacology"},{"key":"1025_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/13543784.2020.1764534","volume":"296","author":"EJ Glotfelty","year":"2020","unstructured":"Glotfelty EJ, Olson L, Karlsson TE, Li Y, Greig NH. Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson\u2019s disease. Expert Opin Investig Drugs. 2020;296:595\u2013602.","journal-title":"Expert Opin Investig Drugs"},{"key":"1025_CR20","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/0963689717721234","volume":"269","author":"DS Kim","year":"2017","unstructured":"Kim DS, Choi H-I, Wang Y, Luo Y, Hoffer BJ, Greig NH. A new treatment strategy for Parkinson\u2019s disease through the gut\u2013brain axis: the glucagon-like peptide-1 receptor pathway. Cell Transplant. 2017;269:1560\u201371.","journal-title":"Cell Transplant"},{"key":"1025_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.bbrc.2014.03.004","volume":"4461","author":"PE Morales","year":"2014","unstructured":"Morales PE, Torres G, Sotomayor-Flores C, Pe\u00f1a-Oyarz\u00fan D, Rivera-Mej\u00edas P, Paredes F, Chiong M. GLP-1 promotes mitochondrial metabolism in vascular smooth muscle cells by enhancing endoplasmic reticulum\u2013mitochondria coupling. Biochem Biophys Res Commun. 2014;4461:410\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1025_CR22","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1038\/s41598-017-02838-2","volume":"71","author":"R Carlessi","year":"2017","unstructured":"Carlessi R, Chen Y, Rowlands J, Cruzat VF, Keane KN, Egan L, Mamotte C, Stokes R, Gunton JE, Bittencourt PIHD. GLP-1 receptor signalling promotes \u03b2-cell glucose metabolism via mTOR-dependent HIF-1\u03b1 activation. Sci Rep. 2017;71:2661.","journal-title":"Sci Rep"},{"key":"1025_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cmet.2020.05.001","volume":"316","author":"K Timper","year":"2020","unstructured":"Timper K, del R\u00edo-Mart\u00edn A, Cremer AL, Bremser S, Alber J, Giavalisco P, Varela L, Heilinger C, Nolte H, Trifunovic A. GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function. Cell Metabol. 2020;316:1189-205. e13.","journal-title":"Cell Metabol"},{"key":"1025_CR24","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","volume":"39010103","author":"D Athauda","year":"2017","unstructured":"Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T. Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet. 2017;39010103:1664\u201375.","journal-title":"Lancet"},{"key":"1025_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.nbd.2018.11.023","volume":"124","author":"M Bader","year":"2019","unstructured":"Bader M, Li Y, Lecca D, Rubovitch V, Tweedie D, Glotfelty E, Rachmany L, Kim HK, Choi HI, Hoffer BJ, Pick CG, Greig NH, Kim DS. Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury. Neurobiol Dis. 2019;124:439\u201353.","journal-title":"Neurobiol Dis"},{"key":"1025_CR26","doi-asserted-by":"publisher","first-page":"17208","DOI":"10.1038\/s41598-019-53356-2","volume":"91","author":"Y Li","year":"2019","unstructured":"Li Y, Vaughan KL, Tweedie D, Jung J, Kim HK, Choi HI, Kim DS, Mattison JA, Greig NH. Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon. Sci Rep. 2019;91:17208.","journal-title":"Sci Rep"},{"key":"1025_CR27","unstructured":"Peptron I. January 15. On-going phase II study of PT320, a long-acting Exenatide, the First-In-Class Drug for Parkinson's Disease Therapy. <http:\/\/www.peptron.com\/ds6_2_1.html>. Accessed 15 Jan 2024."},{"key":"1025_CR28","unstructured":"Peptron I. January 15. SmartDepot Technology. <http:\/\/www.peptron.com\/ds2_2_1.html>. Accessed 15 Jan 2024."},{"key":"1025_CR29","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.cmet.2015.05.007","volume":"216","author":"T Varanita","year":"2015","unstructured":"Varanita T, Soriano ME, Romanello V, Zaglia T, Quintana-Cabrera R, Semenzato M, Menab\u00f2 R, Costa V, Civiletto G, Pesce P. The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage. Cell Metabol. 2015;216:834\u201344.","journal-title":"Cell Metabol"},{"key":"1025_CR30","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1021\/acsptsci.1c00013","volume":"42","author":"V Wang","year":"2021","unstructured":"Wang V, Kuo T-T, Huang EY-K, Ma K-H, Chou Y-C, Fu Z-Y, Lai L-W, Jung J, Choi H-I, Choi D-S. Sustained release GLP-1 Agonist PT320 delays disease progression in a mouse model of Parkinson\u2019s disease. ACS Pharmacol Transl Sci. 2021;42:858\u201369.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1025_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1083\/jcb.30.1.23","volume":"301","author":"ER Weibel","year":"1966","unstructured":"Weibel ER, Kistler GS, Scherle WF. Practical stereological methods for morphometric cytology. J Cell Biol. 1966;301:23\u201338.","journal-title":"J Cell Biol"},{"key":"1025_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/antiox8060171","volume":"86","author":"V Rybka","year":"2019","unstructured":"Rybka V, Suzuki YJ, Gavrish AS, Dibrova VA, Gychka SG, Shults NV. Transmission electron microscopy study of mitochondria in aging brain synapses. Antioxidants. 2019;86:171.","journal-title":"Antioxidants"},{"key":"1025_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/9780470942390.mo140061","volume":"52","author":"C Cant\u00f3","year":"2015","unstructured":"Cant\u00f3 C, Garcia-Roves PM. High-Resolution Respirometry for Mitochondrial Characterization of Ex Vivo Mouse Tissues. Curr Protoc Mouse Biol. 2015;52:135\u201353.","journal-title":"Curr Protoc Mouse Biol"},{"key":"1025_CR34","doi-asserted-by":"crossref","unstructured":"Pesta D and Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Mitochondrial bioenergetics: methods and protocols. 2012:25-58.","DOI":"10.1007\/978-1-61779-382-0_3"},{"key":"1025_CR35","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1038\/s41598-017-02838-2","volume":"71","author":"R Carlessi","year":"2017","unstructured":"Carlessi R, Chen Y, Rowlands J, Cruzat VF, Keane KN, Egan L, Mamotte C, Stokes R, Gunton JE, Bittencourt PIH, Newsholme P. GLP-1 receptor signalling promotes beta-cell glucose metabolism via mTOR-dependent HIF-1alpha activation. Sci Rep. 2017;71:2661.","journal-title":"Sci Rep"},{"key":"1025_CR36","doi-asserted-by":"publisher","first-page":"639145","DOI":"10.3389\/fnmol.2021.639145","volume":"14","author":"T-T Kuo","year":"2021","unstructured":"Kuo T-T, Wang V, Wu J-S, Chen Y-H, Tseng K-Y. Post-stroke delivery of valproic acid promotes functional recovery and differentially modifies responses of peri-infarct microglia. Front Mol Neurosci. 2021;14:639145.","journal-title":"Front Mol Neurosci"},{"key":"1025_CR37","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1261\/rna.053959.115","volume":"226","author":"NJ Schurch","year":"2016","unstructured":"Schurch NJ, Schofield P, Gierli\u0144ski M, Cole C, Sherstnev A, Singh V, Wrobel N, Gharbi K, Simpson GG, Owen-Hughes T. How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use? Rna. 2016;226:839\u201351.","journal-title":"Rna"},{"key":"1025_CR38","first-page":"1","volume":"1512","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;1512:1\u201321.","journal-title":"Genome Biol"},{"key":"1025_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41467-017-00050-4","volume":"81","author":"SME Sahraeian","year":"2017","unstructured":"Sahraeian SME, Mohiyuddin M, Sebra R, Tilgner H, Afshar PT, Au KF, Bani Asadi N, Gerstein MB, Wong WH, Snyder MP. Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis. Nat Commun. 2017;81:59.","journal-title":"Nat Commun"},{"key":"1025_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"124","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;124:357\u201360.","journal-title":"Nat Methods"},{"key":"1025_CR41","first-page":"71","volume":"33","author":"X Rao","year":"2013","unstructured":"Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2\u02c6 (\u2013delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013;33:71.","journal-title":"Biostat Bioinforma Biomath"},{"key":"1025_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"254","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods. 2001;254:402\u20138.","journal-title":"Methods"},{"key":"1025_CR43","doi-asserted-by":"publisher","first-page":"e71448","DOI":"10.1371\/journal.pone.0071448","volume":"88","author":"MV Matz","year":"2013","unstructured":"Matz MV, Wright RM, Scott JG. No control genes required: BAYESIAN analysis of qRT-PCR data. PloS one. 2013;88:e71448.","journal-title":"PloS one"},{"key":"1025_CR44","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.3390\/ijms20246251","volume":"2024","author":"Y-H Chen","year":"2019","unstructured":"Chen Y-H, Wang V, Huang EY-K, Chou Y-C, Kuo T-T, Olson L, Hoffer BJ. Delayed dopamine dysfunction and motor deficits in female Parkinson model mice. Int J Mol Sci. 2019;2024:6251.","journal-title":"Int J Mol Sci"},{"key":"1025_CR45","doi-asserted-by":"crossref","unstructured":"Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcel\u00f3-Coblijn GC and Nussbaum RL. Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking \u03b1-synuclein. Mol Cell Biol. 2005.","DOI":"10.1128\/MCB.25.22.10190-10201.2005"},{"key":"1025_CR46","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"1633","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y. Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem Biophys Res Commun. 1989;1633:1450\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1025_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuron.2004.07.012","volume":"433","author":"J Shen","year":"2004","unstructured":"Shen J, Cookson MR. Mitochondria and dopamine: new insights into recessive parkinsonism. Neuron. 2004;433:301\u20134.","journal-title":"Neuron"},{"key":"1025_CR48","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"396","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease: mechanisms and models. Neuron. 2003;396:889\u2013909.","journal-title":"Neuron"},{"key":"1025_CR49","doi-asserted-by":"publisher","first-page":"42655","DOI":"10.1074\/jbc.M505910200","volume":"28052","author":"R Ved","year":"2005","unstructured":"Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A, Hoener M, Rodrigues CM, Alfonso A, Steer C. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of \u03b1-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J Biol Chem. 2005;28052:42655\u201368.","journal-title":"J Biol Chem"},{"key":"1025_CR50","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"3025646","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science. 2003;3025646:819\u201322.","journal-title":"Science"},{"key":"1025_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"1341","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson\u2019s disease. Mol Brain Res. 2005;1341:57\u201366.","journal-title":"Mol Brain Res"},{"key":"1025_CR52","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"312","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci. 2000;312:1301\u20136.","journal-title":"Nat Neurosci"},{"key":"1025_CR53","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"2334","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT. Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci. 2003;2334:10756\u201364.","journal-title":"J Neurosci"},{"key":"1025_CR54","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"2194587","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;2194587:979\u201380.","journal-title":"Science"},{"key":"1025_CR55","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"385","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006;385:515\u20137.","journal-title":"Nat Genet"},{"key":"1025_CR56","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ng1778","volume":"385","author":"Y Kraytsberg","year":"2006","unstructured":"Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006;385:518\u201320.","journal-title":"Nat Genet"},{"key":"1025_CR57","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4093\/dmj.2021.0138","volume":"456","author":"J-H Koh","year":"2021","unstructured":"Koh J-H, Kim Y-W, Seo D-Y, Sohn T-S. Mitochondrial TFAM as a signaling regulator between cellular organelles: a perspective on metabolic diseases. Diabetes Metabol J. 2021;456:853\u201365.","journal-title":"Diabetes Metabol J"},{"key":"1025_CR58","doi-asserted-by":"publisher","first-page":"e0255355","DOI":"10.1371\/journal.pone.0255355","volume":"167","author":"R Kuroda","year":"2021","unstructured":"Kuroda R, Tominaga K, Kasashima K, Kuroiwa K, Sakashita E, Hayakawa H, Kouki T, Ohno N, Kawai K, Endo H. Loss of mitochondrial transcription factor A in neural stem cells leads to immature brain development and triggers the activation of the integral stress response in vivo. Plos one. 2021;167:e0255355.","journal-title":"Plos one"},{"key":"1025_CR59","doi-asserted-by":"publisher","first-page":"11609","DOI":"10.18632\/oncotarget.7018","volume":"710","author":"D Xie","year":"2016","unstructured":"Xie D, Wu X, Lan L, Shangguan F, Lin X, Chen F, Xu S, Zhang Y, Chen Z, Huang K. Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK\/p38MAPK signaling and reducing cellular bioenergetics. Oncotarget. 2016;710:11609.","journal-title":"Oncotarget"},{"key":"1025_CR60","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/cdd.2013.115","volume":"2012","author":"A Dickinson","year":"2013","unstructured":"Dickinson A, Yeung K, Donoghue J, Baker M, Kelly RD, McKenzie M, Johns TG, St John JC. The regulation of mitochondrial DNA copy number in glioblastoma cells. Cell Death Differ. 2013;2012:1644\u201353.","journal-title":"Cell Death Differ"},{"key":"1025_CR61","doi-asserted-by":"publisher","first-page":"e115433","DOI":"10.1371\/journal.pone.0115433","volume":"912","author":"DL Nile","year":"2014","unstructured":"Nile DL, Brown AE, Kumaheri MA, Blair HR, Heggie A, Miwa S, Cree LM, Payne B, Chinnery PF, Brown L. Age-related mitochondrial DNA depletion and the impact on pancreatic Beta cell function. Plos one. 2014;912:e115433.","journal-title":"Plos one"},{"key":"1025_CR62","doi-asserted-by":"publisher","first-page":"110635","DOI":"10.1016\/j.diabres.2023.110635","volume":"199","author":"M Vaittinen","year":"2023","unstructured":"Vaittinen M, Ilha M, Herbers E, Wagner A, Virtanen KA, Pietil\u00e4inen KH, Pirinen E, Pihlajam\u00e4ki J. Liraglutide demonstrates a therapeutic effect on mitochondrial dysfunction in human SGBS adipocytes in vitro. Diabetes Res Clin Pract. 2023;199:110635.","journal-title":"Diabetes Res Clin Pract"},{"key":"1025_CR63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1440-1681.13590","volume":"491","author":"A Durak","year":"2022","unstructured":"Durak A, Akkus E, Canpolat AG, Tuncay E, Corapcioglu D, Turan B. Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction. Clin Exp Pharmacol Physiol. 2022;491:46\u201359.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1025_CR64","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3803\/EnM.2015.30.2.216","volume":"302","author":"MY Kang","year":"2015","unstructured":"Kang MY, Oh TJ, Cho YM. Glucagon-like peptide-1 increases mitochondrial biogenesis and function in INS-1 rat insulinoma cells. Endocrinol Metabol. 2015;302:216\u201320.","journal-title":"Endocrinol Metabol"},{"key":"1025_CR65","doi-asserted-by":"publisher","first-page":"114578","DOI":"10.1016\/j.bcp.2021.114578","volume":"188","author":"Y Xie","year":"2021","unstructured":"Xie Y, Zheng J, Li S, Li H, Zhou Y, Zheng W, Zhang M, Liu L, Chen Z. GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer\u2019s disease by regulating mitochondrial dysfunction via the cAMP\/PKA pathway. Biochem Pharmacol. 2021;188:114578.","journal-title":"Biochem Pharmacol"},{"key":"1025_CR66","doi-asserted-by":"crossref","unstructured":"Kopp KO, Glotfelty EJ, Li Y and Greig NH. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Pharmacol res. 2022:106550.","DOI":"10.1016\/j.phrs.2022.106550"},{"key":"1025_CR67","doi-asserted-by":"publisher","first-page":"e12932","DOI":"10.1111\/jne.12932","volume":"334","author":"M Schell","year":"2021","unstructured":"Schell M, Wardelmann K, Kleinridders A. Untangling the effect of insulin action on brain mitochondria and metabolism. J Neuroendocrinol. 2021;334:e12932.","journal-title":"J Neuroendocrinol"},{"key":"1025_CR68","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"215","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov Today. 2016;215:802\u201318.","journal-title":"Drug Discov Today"},{"key":"1025_CR69","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.bbamem.2017.03.013","volume":"18596","author":"N Ikon","year":"2017","unstructured":"Ikon N, Ryan RO. Cardiolipin and mitochondrial cristae organization. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2017;18596:1156\u201363.","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"key":"1025_CR70","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1083\/jcb.200605138","volume":"1752","author":"F Vogel","year":"2006","unstructured":"Vogel F, Bornh\u00f6vd C, Neupert W, Reichert AS. Dynamic subcompartmentalization of the mitochondrial inner membrane. J Cell Biol. 2006;1752:237\u201347.","journal-title":"J Cell Biol"},{"key":"1025_CR71","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0014-5793(03)00633-1","volume":"5462\u20133","author":"RW Gilkerson","year":"2003","unstructured":"Gilkerson RW, Selker JM, Capaldi RA. The cristal membrane of mitochondria is the principal site of oxidative phosphorylation. FEBS Lett. 2003;5462\u20133:355\u20138.","journal-title":"FEBS Lett"},{"key":"1025_CR72","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.devcel.2021.02.009","volume":"567","author":"MYW Ng","year":"2021","unstructured":"Ng MYW, Wai T, Simonsen A. Quality control of the mitochondrion. Dev Cell. 2021;567:881\u2013905.","journal-title":"Dev Cell"},{"issue":"268\u201378","key":"1025_CR73","volume":"253","author":"L Miret-Casals","year":"2018","unstructured":"Miret-Casals L, Sebastian D, Brea J, Rico-Leo EM, Palacin M, Fern\u00e1ndez-Salguero PM, Loza MI, Albericio F, Zorzano A. Identification of new activators of mitochondrial fusion reveals a link between mitochondrial morphology and pyrimidine metabolism. Cell Chem Biol. 2018;253(268\u201378): e4.","journal-title":"Cell Chem Biol"},{"key":"1025_CR74","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","volume":"683","author":"M Funayama","year":"2023","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N. Molecular genetics of Parkinson\u2019s disease: contributions and global trends. J Hum Genet. 2023;683:125\u201330.","journal-title":"J Hum Genet"},{"key":"1025_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ana.24410","volume":"781","author":"V Carelli","year":"2015","unstructured":"Carelli V, Musumeci O, Caporali L, Zanna C, La Morgia C, Del Dotto V, Porcelli AM, Rugolo M, Valentino ML, Iommarini L. Syndromic parkinsonism and dementia associated with OPA 1 missense mutations. Ann Neurol. 2015;781:21\u201338.","journal-title":"Ann Neurol"},{"key":"1025_CR76","doi-asserted-by":"crossref","unstructured":"Drucker DJ, Holst JJ. The expanding incretin universe: from basic biology to clinical translation. Diabetologia. 2023:1-15.","DOI":"10.1007\/s00125-023-05906-7"},{"key":"1025_CR77","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/hmg\/dds003","volume":"219","author":"X Wang","year":"2012","unstructured":"Wang X, Yan MH, Fujioka H, Liu J, Wilson-Delfosse A, Chen SG, Perry G, Casadesus G, Zhu X. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet. 2012;219:1931\u201344.","journal-title":"Hum Mol Genet"},{"key":"1025_CR78","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.neurobiolaging.2012.02.001","volume":"3312","author":"Y-X Gui","year":"2012","unstructured":"Gui Y-X, Wang X-Y, Kang W-Y, Zhang Y-J, Zhang Y, Zhou Y, Quinn TJ, Liu J, Chen S-D. Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1. Neurobiol Aging. 2012;3312:2841\u201354.","journal-title":"Neurobiol Aging"},{"key":"1025_CR79","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1038\/emboj.2010.223","volume":"2920","author":"F Kamp","year":"2010","unstructured":"Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K. Inhibition of mitochondrial fusion by \u03b1-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J. 2010;2920:3571\u201389.","journal-title":"EMBO J"},{"key":"1025_CR80","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.mito.2019.06.002","volume":"49","author":"B Whitley","year":"2019","unstructured":"Whitley B, Engelhart E, Hoppins S. Mitochondrial dynamics and their potential as a therapeutic target. Mitochondrion. 2019;49:269\u201383.","journal-title":"Mitochondrion"},{"key":"1025_CR81","doi-asserted-by":"crossref","unstructured":"Galindo MF, Solesio ME, Atienzar-Aroca S, Zamora MJ and Jordan Bueso J. Mitochondrial dynamics and mitophagy in the 6-hydroxydopamine preclinical model of Parkinson's disease. Parkinson\u2019s Dis. 2012;2012.","DOI":"10.1155\/2012\/131058"},{"key":"1025_CR82","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mito.2019.11.006","volume":"51","author":"S Jang","year":"2020","unstructured":"Jang S, Javadov S. OPA1 regulates respiratory supercomplexes assembly: the role of mitochondrial swelling. Mitochondrion. 2020;51:30\u20139.","journal-title":"Mitochondrion"},{"key":"1025_CR83","doi-asserted-by":"crossref","unstructured":"Fry MY, Navarro PP, Qin X, Inde Z, Ananda VY, Lugo CM, Hakim P, Luce BE, Ge Y and McDonald JL. In situ architecture of Opa1-dependent mitochondrial cristae remodeling. bioRxiv. 2023:2023.01. 16.524176.","DOI":"10.1101\/2023.01.16.524176"},{"key":"1025_CR84","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1074\/jbc.RA119.010983","volume":"29519","author":"H Lee","year":"2020","unstructured":"Lee H, Smith SB, Sheu S-S, Yoon Y. The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress. J Biol Chem. 2020;29519:6543\u201360.","journal-title":"J Biol Chem"},{"key":"1025_CR85","doi-asserted-by":"publisher","first-page":"955258","DOI":"10.3389\/fnsyn.2022.955258","volume":"14","author":"C H\u00f6lscher","year":"2022","unstructured":"H\u00f6lscher C. Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Synaptic Neurosci. 2022;14:955258.","journal-title":"Front Synaptic Neurosci"},{"key":"1025_CR86","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41380-022-01792-4","volume":"281","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Edison P. Incretin and insulin signaling as novel therapeutic targets for Alzheimer\u2019s and Parkinson\u2019s disease. Mol Psychiatry. 2023;281:217\u201329.","journal-title":"Mol Psychiatry"},{"key":"1025_CR87","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/bph.15508","volume":"1794","author":"C H\u00f6lscher","year":"2022","unstructured":"H\u00f6lscher C. Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders. Br J Pharmacol. 2022;1794:695\u2013714.","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-024-01025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-024-01025-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-024-01025-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T22:04:31Z","timestamp":1713305071000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-024-01025-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1025"],"URL":"https:\/\/doi.org\/10.1186\/s12929-024-01025-6","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols were approved by the NDMC Animal Care and Use Committee (IACUC 20-128 and IACUC 22-008) in accordance with NIH guidelines (DHEW publications 85-23) Animals were house in our AAALAC accredited animal facility at NDMC). No human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (the manuscript does not contain any individual person\u2019s data in any form).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H-I.C. and J.J. are employees of Peptron Inc. The Intramural Research Program of the National Institute on Aging, N.I.H., and Peptron Inc. have a Cooperative Research and Development Agreement to develop Exenatide as a treatment strategy for neurodegenerative disorders for which NIA and Peptron Inc. hold patent rights via the work of H-I.C. and N.H.G. All other authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}